Annual CFI
$310.14 M
+$245.04 M+376.39%
31 December 2023
Summary:
Ascendis Pharma A/S annual cash flow from investing activities is currently $310.14 million, with the most recent change of +$245.04 million (+376.39%) on 31 December 2023. During the last 3 years, it has risen by +$440.97 million (+337.05%). ASND annual CFI is now at all-time high.ASND Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
01 September 2024
Summary:
Ascendis Pharma A/S quarterly cash flow from investing activities is not available.ASND Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
01 September 2024
Summary:
Ascendis Pharma A/S TTM cash flow from investing activities is not available.ASND TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASND Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +337.1% | - | - |
| 5 y5 years | +5469.9% | - | - |
ASND Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +337.1% | ||||
| 5 y | 5 years | at high | +193.3% | ||||
| alltime | all time | at high | +193.3% |
Ascendis Pharma A/S Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $7.77 M(+42.0%) | $91.67 M(-70.4%) |
| Dec 2023 | $310.14 M(+376.4%) | $5.47 M(-77.0%) | $310.14 M(+1.1%) |
| Sept 2023 | - | $23.77 M(-56.5%) | $306.78 M(+4.2%) |
| June 2023 | - | $54.66 M(-75.8%) | $294.42 M(+18.7%) |
| Mar 2023 | - | $226.24 M(>+9900.0%) | $248.10 M(+281.1%) |
| Dec 2022 | $65.10 M(-149.8%) | $2.11 M(-81.5%) | $65.10 M(-193.8%) |
| Sept 2022 | - | $11.40 M(+36.8%) | -$69.43 M(+23.4%) |
| June 2022 | - | $8.34 M(-80.7%) | -$56.25 M(+9.7%) |
| Mar 2022 | - | $43.25 M(-132.7%) | -$51.29 M(-60.8%) |
| Dec 2021 | -$130.83 M(-60.7%) | -$132.42 M(-638.7%) | -$130.83 M(+77.7%) |
| Sept 2021 | - | $24.58 M(+84.9%) | -$73.63 M(-14.7%) |
| June 2021 | - | $13.29 M(-136.6%) | -$86.30 M(-76.2%) |
| Mar 2021 | - | -$36.29 M(-51.7%) | -$362.07 M(+8.9%) |
| Dec 2020 | -$332.56 M(+5658.1%) | -$75.21 M(-731.7%) | -$332.56 M(+28.6%) |
| Sept 2020 | - | $11.91 M(-104.5%) | -$258.64 M(-4.9%) |
| June 2020 | - | -$262.48 M(+3773.1%) | -$271.91 M(+2689.4%) |
| Mar 2020 | - | -$6.78 M(+423.5%) | -$9.75 M(+68.8%) |
| Dec 2019 | -$5.78 M(+84.7%) | -$1.29 M(-4.7%) | -$5.78 M(+0.2%) |
| Sept 2019 | - | -$1.36 M(+326.5%) | -$5.76 M(+0.6%) |
| June 2019 | - | -$318.40 K(-88.6%) | -$5.73 M(-1.3%) |
| Mar 2019 | - | -$2.80 M(+118.9%) | -$5.81 M(+85.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$3.13 M(+193.4%) | -$1.28 M(-3.2%) | -$3.13 M(+50.3%) |
| Sept 2018 | - | -$1.32 M(+233.8%) | -$2.08 M(+120.5%) |
| June 2018 | - | -$396.50 K(+216.4%) | -$943.80 K(+19.6%) |
| Mar 2018 | - | -$125.30 K(-46.8%) | -$789.30 K(-25.9%) |
| Dec 2017 | -$1.07 M(+43.3%) | -$235.70 K(+26.5%) | -$1.07 M(+13.7%) |
| Sept 2017 | - | -$186.30 K(-23.0%) | -$937.50 K(+1.4%) |
| June 2017 | - | -$242.00 K(-39.7%) | -$924.20 K(-6.9%) |
| Mar 2017 | - | -$401.60 K(+273.2%) | -$993.20 K(+33.5%) |
| Dec 2016 | -$743.70 K(-35.5%) | -$107.60 K(-37.8%) | -$743.80 K(-28.3%) |
| Sept 2016 | - | -$173.00 K(-44.4%) | -$1.04 M(+7.9%) |
| June 2016 | - | -$311.00 K(+104.3%) | -$962.00 K(-20.4%) |
| Mar 2016 | - | -$152.20 K(-62.1%) | -$1.21 M(+4.8%) |
| Dec 2015 | -$1.15 M(+114.1%) | -$401.70 K(+313.7%) | -$1.15 M(+43.3%) |
| Sept 2015 | - | -$97.10 K(-82.6%) | -$804.80 K(+3.7%) |
| June 2015 | - | -$557.20 K(+474.4%) | -$775.80 K(+67.1%) |
| Mar 2015 | - | -$97.00 K(+81.3%) | -$464.30 K(-13.8%) |
| Dec 2014 | -$538.60 K(-66.1%) | -$53.50 K(-21.4%) | -$538.60 K(+11.0%) |
| Sept 2014 | - | -$68.10 K(-72.3%) | -$485.10 K(+16.3%) |
| June 2014 | - | -$245.70 K(+43.4%) | -$417.00 K(+143.4%) |
| Mar 2014 | - | -$171.30 K | -$171.30 K |
| Dec 2013 | -$1.59 M(+324.2%) | - | - |
| Dec 2012 | -$374.10 K | - | - |
FAQ
- What is Ascendis Pharma A/S annual cash flow from investing activities?
- What is the all time high annual CFI for Ascendis Pharma A/S?
- What is the all time high quarterly CFI for Ascendis Pharma A/S?
- What is the all time high TTM CFI for Ascendis Pharma A/S?
What is Ascendis Pharma A/S annual cash flow from investing activities?
The current annual CFI of ASND is $310.14 M
What is the all time high annual CFI for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual cash flow from investing activities is $310.14 M
What is the all time high quarterly CFI for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly cash flow from investing activities is $226.24 M
What is the all time high TTM CFI for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM cash flow from investing activities is $310.14 M